The genetic architecture of Parkinson's disease

Parkinson's disease is a complex neurodegenerative disorder for which both rare and common genetic variants contribute to disease risk, onset, and progression. Mutations in more than 20 genes have been associated with the disease, most of which are highly penetrant and often cause early onset o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lancet neurology Jg. 19; H. 2; S. 170 - 178
Hauptverfasser: Blauwendraat, Cornelis, Nalls, Mike A, Singleton, Andrew B
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Elsevier Ltd 01.02.2020
Elsevier Limited
Schlagworte:
Alleles
Dementia - genetics
Deoxyribonucleic acid
Disease Progression
DNA
Genes
Genetic diversity
Genetic Predisposition to Disease - genetics
Genetic variability
Genetics
Genome-wide association studies
Genome-Wide Association Study
Genomes
Humans
Kinases
Learning algorithms
Movement disorders
Mutation
Mutation - genetics
Neurodegenerative diseases
Neurodegenerative Diseases - diagnosis
Neurodegenerative Diseases - genetics
Parkinson Disease - diagnosis
Parkinson Disease - genetics
Parkinson's disease
Ribonucleic acid
Risk Factors
RNA
ISSN:1474-4422, 1474-4465, 1474-4465
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Parkinson's disease is a complex neurodegenerative disorder for which both rare and common genetic variants contribute to disease risk, onset, and progression. Mutations in more than 20 genes have been associated with the disease, most of which are highly penetrant and often cause early onset or atypical symptoms. Although our understanding of the genetic basis of Parkinson's disease has advanced considerably, much remains to be done. Further disease-related common genetic variability remains to be identified and the work in identifying rare risk alleles has only just begun. To date, genome-wide association studies have identified 90 independent risk-associated variants. However, most of them have been identified in patients of European ancestry and we know relatively little of the genetics of Parkinson's disease in other populations. We have a limited understanding of the biological functions of the risk alleles that have been identified, although Parkinson's disease risk variants appear to be in close proximity to known Parkinson's disease genes and lysosomal-related genes. In the past decade, multiple efforts have been made to investigate the genetic architecture of Parkinson's disease, and emerging technologies, such as machine learning, single-cell RNA sequencing, and high-throughput screens, will improve our understanding of genetic risk.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
CB, MAN, and ABS wrote the manuscript and all authors were responsible for its review and critique.
Contributors
ISSN:1474-4422
1474-4465
1474-4465
DOI:10.1016/S1474-4422(19)30287-X